Katsuji Inoue Selected Research

Katsuji Inoue Research Topics

Disease

5	Heart Failure 01/2022 - 01/2005
5	Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy) 12/2015 - 05/2010
5	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 09/2012 - 01/2005
3	Pathologic Constriction (Stenosis) 01/2021 - 09/2012
2	Thrombosis (Thrombus) 12/2020 - 08/2011
2	Cardiomyopathies (Cardiomyopathy) 08/2020 - 10/2007
2	Atrial Fibrillation 09/2016 - 08/2011
2	Fibrosis (Cirrhosis) 07/2012 - 02/2011
2	Rupture 06/2012 - 11/2011
2	Spasm (Spasms) 09/2002 - 06/2002
1	No-Reflow Phenomenon 01/2022
1	Amyloid Plaque 01/2021
1	Amyloidosis 01/2021
1	Aortic Valve Stenosis (Aortic Stenosis) 08/2020
1	Tachycardia (Tachyarrhythmias) 01/2020
1	Myocardial Ischemia (Ischemic Heart Diseases) 01/2020
1	Stable Angina 01/2020
1	Ventricular Tachycardia 12/2015
1	Sarcoidosis (Schaumann Disease) 10/2014
1	Coronary Stenosis (Coronary Artery Stenosis) 01/2013
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2013
1	Takotsubo Cardiomyopathy 09/2012
1	Cardiovascular Diseases (Cardiovascular Disease) 07/2012
1	Inflammation (Inflammations) 06/2012
1	Atherosclerosis 06/2012
1	Atherosclerotic Plaque (Atheroma) 06/2012
1	Diverticulum 08/2011
1	AIDS-Related Complex (ARC) 11/2010
1	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 05/2010
1	Hypoglycemia (Reactive Hypoglycemia) 10/2007
1	Hepatomegaly 10/2007
1	Pulmonary Hypertension 01/2005
1	Familial Primary Pulmonary Hypertension 01/2005
1	Angina Pectoris 01/2005
1	Ventricular Remodeling 07/2004
1	Myocardial Infarction 07/2004
1	Heart Diseases (Heart Disease) 07/2004
1	Chest Pain (Chest Pains) 09/2002

Drug/Important Bio-Agent (IBA)

2	Prealbumin (Transthyretin)IBA 01/2021 - 08/2020
2	Amyloid (Amyloid Fibrils)IBA 01/2021 - 08/2020
2	Cytidine Triphosphate (CTP)IBA 01/2020 - 01/2013
2	GadoliniumIBA 07/2012 - 02/2011
2	CytokinesIBA 06/2012 - 07/2004
2	LipidsIBA 06/2012 - 11/2010
2	cifenline (cibenzoline)IBA 02/2011 - 05/2010
2	Acetylcholine (Acetylcholine Chloride)FDA Link 09/2002 - 06/2002
1	Tolvaptan FDA Link 01/2022
1	Oxygen (Dioxygen)IBA 12/2020
1	Adenosine Triphosphate (ATP)IBA 01/2020
1	SteroidsIBA 10/2014
1	CalciumIBA 10/2013
1	Type 1 Angiotensin ReceptorIBA 06/2012
1	Angiotensin IIIBA 06/2012
1	ApolipoproteinsIBA 06/2012
1	Apolipoproteins E (ApoE)IBA 06/2012
1	NADP (NADPH)IBA 06/2012
1	Oxidoreductases (Dehydrogenase)IBA 06/2012
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 06/2012
1	Matrix Metalloproteinases (MMPs)IBA 06/2012
1	Polyethylene (Polythene)IBA 06/2012
1	Adrenergic Receptors (Adrenergic Receptor)IBA 01/2012
1	Adrenergic Agents (Adrenergic Drugs)IBA 01/2012
1	MetalsIBA 11/2011
1	Insulin (Novolin)FDA Link 07/2011
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 05/2010
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 08/2009
1	Nonsense Codon (Nonsense Mutation)IBA 10/2007
1	Glycogen Debranching Enzyme System (Glycogen Debranching Enzyme)IBA 10/2007
1	Biomarkers (Surrogate Marker)IBA 06/2005
1	Thallium-201IBA 01/2005
1	Interleukin-6 (Interleukin 6)IBA 07/2004
1	ozagrelIBA 09/2002
1	Thromboxane A2 (A2, Thromboxane)IBA 09/2002
1	ThromboxanesIBA 09/2002
1	Phenobarbital (Luminal)FDA Link 06/2002

Therapy/Procedure

5	Therapeutics 10/2014 - 07/2004
3	Stents 01/2022 - 11/2011
3	Catheter Ablation 09/2016 - 08/2011
2	Percutaneous Coronary Intervention 01/2022 - 01/2005
1	Sutures (Suture) 01/2022
1	Contraindications 12/2020
1	Heart Transplantation (Grafting, Heart) 12/2020
1	Radiofrequency Ablation 01/2020
1	Catheters 09/2012
1	Cardiac Resynchronization Therapy 09/2012
1	Ligation 06/2012